Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lokelma for Maximisation of RAAS Inhibition in CKD Patients With Heart Failure
NCT05004363Phase 3Completed
- Sponsor
- St George's, University of London
- Start
- Jan 2022
- Primary completion
- Jul 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by St George's, University of London. Started Jan 2022; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT05004363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004363.